Group 1 - The company, Universal Medical (02666.HK), announced the issuance of its first phase of notes by its wholly-owned subsidiary, Universal Global International Financing Leasing (Tianjin) Co., Ltd., with a total issuance amount of RMB 200 million at a fixed interest rate of 2.08% [1] - The notes will mature in two years from November 11, 2025, and were issued at a price equivalent to 100% of their face value [1] - As of November 11, 2025, Universal Medical's stock closed at HKD 6.55, with a trading volume of 4.364 million shares and a turnover of HKD 28.423 million [1] Group 2 - The company has a market capitalization of HKD 12.352 billion, ranking 5th in the medical services sector [2] - Key financial metrics include a Return on Equity (ROE) of 12.39%, revenue of HKD 14.701 billion, and a net profit margin of 17.61% [2] - The company's gross profit margin stands at 34.34%, while its debt ratio is 73.38%, which is slightly lower than the industry average [2]